Close menu
Science Library Category:

Aluminum Poisoning

Published: 2022
SYNOPSIS

To assess the association between cumulative aluminum exposure from vaccines before age 24 months and persistent asthma at age 24 to 59 months.

TITLE

Association Between Aluminum Exposure From Vaccines Before Age 24 Months and Persistent Asthma at Age 24 to 59 Months

CITATION

M. F. Daley, M.D.; L. M. Reifler, MPH; J. M. Glanz, Ph.D.; S. J. Hambidge, M.D., Ph.D.; D. G., M.D., Ph.D.; S. A. Irving, MHS; J. D. Nordin, M.D., MPH; D. L. McClure, Ph.D.; N. P. Klein, M.D., Ph.D.; M. L. Jackson, Ph.D., MPH; S. Kamidani, M.D.; J.Duffy, M.D., MPH; Frank DeStefano, M.D.

SUMMARY

In a large observational study, a positive association was found between vaccine-related aluminum exposure and persistent asthma. While recognizing the small effect sizes identified and the potential for residual confounding, additional investigation of this hypothesis appears warranted.

View Abstract

TAGS
Published: 2020
SYNOPSIS

The CDC vaccine schedule results in a high degree of chronic aluminum toxicity in the first seven months of life.

TITLE

Acute exposure and chronic retention of aluminum in three vaccine schedules and effects of genetic and environmental variation

CITATION

McFarland G, La Joie E, Thomas P, Lyons-Weiler J. Journal of Trace Elements in Medicine and Biology. 2019 Dec 5;58:126444.

SUMMARY

This study shows that the CDC vaccine schedule results in a high degree of chronic aluminum toxicity in the first seven months of life—a time period critically important to neurodevelopment and immune system development. The authors reached this conclusion after assessing “time spent in toxicity” (defined as “the percentage of days of each week an infant spends with a body burden that exceeds the minimum safe level”) for the CDC schedule and two other lower-aluminum schedules. Important safety considerations include aluminum adjuvant dose per vaccine, spacing of aluminum-containing vaccines, the child’s weight at the time of vaccination and genetic variants that may limit ability to clear aluminum. Changes to the vaccine schedule, including use of vaccines that do not contain aluminum, can significantly reduce “time spent in toxicity.”

View Abstract

TAGS
Published: 2019
SYNOPSIS

With the preliminary literature search starting in 2013 and looking backwards in time, research publications revealed a myriad of toxic actions of Aluminum causing pathological conditions.

TITLE

Aluminium toxicosis: a review of toxic actions and effects

CITATION

Ikechukwu Onyebuchi Igbokwe, Ephraim Igwenagu, Nanacha Afifi Igbokwe. Interdiscip Toxicol. 2019; Vol. 12(2): 45–70. doi: 10.2478/intox-2019-0007

SUMMARY

Aluminium (Al) is frequently accessible to animal and human populations to the extent that intoxications may occur. Intake of Al is by inhalation of aerosols or particles, ingestion of food, water and medicaments, skin contact, vaccination, dialysis and infusions. Toxic actions of Al induce oxidative stress, immunologic alterations, genotoxicity, pro-inflammatory effect, peptide denaturation or transformation, enzymatic dysfunction, metabolic derangement, amyloidogenesis, membrane perturbation, iron dyshomeostasis, apoptosis, necrosis and dysplasia. The pathological conditions associated with Al toxicosis are desquamative interstitial pneumonia, pulmonary alveolar proteinosis, granulomas, granulomatosis and fibrosis, toxic myocarditis, thrombosis and ischemic stroke, granulomatous enteritis, Crohn’s disease, inflammatory bowel diseases, anemia, Alzheimer’s disease, dementia, sclerosis, autism, macrophagic myofasciitis, osteomalacia, oligospermia and infertility, hepatorenal disease, breast cancer and cyst, pancreatitis, pancreatic necrosis and diabetes mellitus. The review provides a broad overview of Al toxicosis as a background for sustained investigations of the toxicology of Al compounds of public health importance.

View Abstract

TAGS